Ferhun Balkanci
Overview
Explore the profile of Ferhun Balkanci including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
197
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ocal O, Eldem G, Karagoz A, Kilickap S, Yalcin S, Balkanci F, et al.
Cureus
. 2021 Oct;
13(9):e17880.
PMID: 34660079
Objectives Chemosaturation with percutaneous hepatic perfusion (PHP) is a relatively new minimally-invasive liver-directed therapy, which aims to deliver high-dose chemotherapy into the liver with low systemic side effects. Initial studies...
2.
Cil B, Ocal O, Eldem F, Peynircioglu B, Balkanci F
J Vasc Interv Radiol
. 2018 Dec;
30(1):69-73.
PMID: 30527656
Purpose: To evaluate the long-term results of and patient satisfaction with trapezius ports in breast cancer patients, as an alternative to chest ports. Patients And Methods: This retrospective study included...
3.
Eldem G, Erdogan E, Peynircioglu B, Arat A, Balkanci F
Diagn Interv Radiol
. 2018 Oct;
25(1):62-70.
PMID: 30272561
Purpose: We aimed to report a single center's experience on endovascular treatment of true renal artery aneurysms (TRAAs), including treatment techniques and outcomes. Methods: This retrospective study was designed to...
4.
Turk G, Eldem G, Kilickap S, Bozkurt F, Salanci B, Cil B, et al.
J Gastrointest Cancer
. 2018 Jan;
50(2):236-243.
PMID: 29354877
Purpose: We aimed to evaluate the efficacy and outcomes of radioembolization with Yttrium-90 (Y-90) microspheres in patients with unresectable and chemorefractory colorectal cancer liver metastasis (CRCLM). Methods: This single-center study...
5.
Ozturk O, Eldem G, Peynircioglu B, Kav T, Gormez A, Cil B, et al.
World J Gastroenterol
. 2016 Dec;
22(43):9623-9630.
PMID: 27920483
Aim: To determine the outcomes of partial splenic embolization (PSE) for massive splenomegaly due to idiopathic portal hypertension (IPH). Methods: In this prospective study, we evaluated the characteristics and prognosis...
6.
Peynircioglu B, Hizal M, Cil B, Deuerling-Zheng Y, von Roden M, Hazirolan T, et al.
Diagn Interv Radiol
. 2014 Dec;
21(1):71-7.
PMID: 25538037
Purpose: We aimed to determine whether the C-arm computed tomography (CT) blood volume (BV) imaging of hepatic tumors performed with a new prototype software is capable of measuring the BV...
7.
Idilman I, Peynircioglu B, Cil B, Doganay Erdogan B, Yalcin S, Bayraktar Y, et al.
Turk J Gastroenterol
. 2013 Aug;
24(2):141-7.
PMID: 23934461
Background/aims: We aimed to determine the effect of transarterial chemoembolization treatment on survival in patients with hepatocellular carcinoma and to investigate the efficacy and tolerability of two different transarterial chemoembolization...
8.
Peynircioglu B, Cil B, Ozkan F, Koc O, Akinci D, Abbasoglu O, et al.
Turk J Gastroenterol
. 2012 Jun;
23(2):148-55.
PMID: 22706743
Background/aims: We aimed to retrospectively evaluate our experience in portal vein embolization that induces hypertrophy of the future liver remnant before right hepatectomy and to determine the differences in outcome...
9.
Duman A, Ersoy O, Abbasoglu O, Harmanci O, Aydinli M, Bayraktar Y, et al.
Indian J Gastroenterol
. 2011 Sep;
30(6):285.
PMID: 21938554
No abstract available.
10.
Efe C, Shorbagi A, Ozseker B, Yilmaz H, Sokmensuer C, Balkanci F, et al.
Rheumatol Int
. 2011 Sep;
32(10):3319-20.
PMID: 21898058
No abstract available.